Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

294 works between 1988 and 2024

1 - 20 of 294 works

2024

Journal Article

Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer

Martini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Douglas A (2024). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 485 (4), 723-728. doi: 10.1007/s00428-023-03643-1

Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer

2024

Journal Article

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

Roberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

2024

Journal Article

Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers

Logan, Jessica M., Martini, Carmela, Sorvina, Alexandra, Johnson, Ian R. D., Brooks, Robert D., Caruso, Maria C., Huzzell, Chelsea, Moore, Courtney R., Karageorgos, Litsa, Butler, Lisa M., Tewari, Prerna, Prabhakaran, Sarita, Hickey, Shane M., Klebe, Sonja, Samaratunga, Hemamali, Delahunt, Brett, Moretti, Kim, O’Leary, John J., Brooks, Douglas A. and Ung, Ben S.-Y. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data, 11 (1) 852, 1. doi: 10.1038/s41597-024-03696-0

Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers

2024

Journal Article

Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen

Samaratunga, Hemamali, Delahunt, Brett, Olsson, Mats, Aly, Markus, Egevad, Lars and Yaxley, John (2024). Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen. Pathology, 56 (7), 1059-1061. doi: 10.1016/j.pathol.2024.05.013

Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen

2024

Journal Article

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars, Micoli, Chiara, Delahunt, Brett, Samaratunga, Hemamali, Orrason, Andri Wilberg, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. Virchows Archiv, 484 (6), 995-1003. doi: 10.1007/s00428-024-03810-y

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

2024

Journal Article

Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars, Micoli, Chiara, Samaratunga, Hemamali, Delahunt, Brett, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. European Urology Oncology, 7 (2), 213-221. doi: 10.1016/j.euo.2023.11.002

Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

2024

Journal Article

UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population

Desai, Devang, Harrison, William, Raveenthiran, Sheliyan, Samaratunga, Hemamali and De Win, Gunter (2024). UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population. Translational Andrology and Urology, 13 (3), 423-432. doi: 10.21037/tau-23-549

UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population

2024

Conference Publication

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

Vis, A., Meijer, D., Roberts, M.J., Siriwardana, A.R., Morton, A., Yaxley, J.W., Samaratunga, H., Emmett, L., Van Der Ven, P.M., Heymans, M.W., Nieuwenhuijzen, J.A., Van Der Poel, H.G., Van Donswijk, M.L., Boellaard, T.N., Schoots, I.G., Stricker, P., Haynes, A-M., Oprea-Lager, D.E., Coughlin, G.D. and Van Leeuwen, P.J. (2024). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00422-6

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

2024

Journal Article

Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients

Samaratunga, Hemamali, Egevad, Lars, Yaxley, John, Perry-Keene, Joanna, Le Fevre, Ian, Kench, James, Matsika, Admire, Bostwick, David, Iczkowski, Kenneth and Delahunt, Brett (2024). Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients. Pathology, 56 (1), 33-38. doi: 10.1016/j.pathol.2023.10.005

Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients

2023

Journal Article

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

Vis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

2023

Journal Article

Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread

Sorvina, Alexandra, Martini, Carmela, Prabhakaran, Sarita, Logan, Jessica M., S-Y. Ung, Benjamin, Moore, Courtney, Johnson, Ian R.D., Lazniewska, Joanna, Tewari, Prerna, Malone, Victoria, Brooks, Robert D., Hickey, Shane M., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Doug A. (2023). Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology, 55 (6), 792-799. doi: 10.1016/j.pathol.2023.05.004

Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread

2023

Journal Article

Web-grading—a tool to test personal grading of renal and prostate cancer

Kristiansen, Glen, Schmid, Matthias, Egevad, Lars, Samaratunga, Hemamali, Varma, Murali, Inam, Kaan, Thiesen, Hans-Jürgen, Delahunt, Brett and Dai, Yulin (2023). Web-grading—a tool to test personal grading of renal and prostate cancer. APMIS, 131 (10), 528-535. doi: 10.1111/apm.13347

Web-grading—a tool to test personal grading of renal and prostate cancer

2023

Journal Article

Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer

Martini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S-Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali, Brooks, Douglas A. and kConFab Consortium (2023). Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 1-1. doi: 10.1007/s00428-023-03666-8

Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer

2023

Journal Article

Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?

Samaratunga, Hemamali, Egevad, Lars and Delahunt, Brett (2023). Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?. Pathology, 56 (1), 141-142. doi: 10.1016/j.pathol.2023.08.005

Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?

2023

Journal Article

Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI

Samaratunga, Hemamali, Hussey, David, Le Fevre, Ian K., Egevad, Lars, Sarikwal, Anubhav, Carim, Humza and Delahunt, Brett (2023). Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI. Pathology, 56 (3), 413-415. doi: 10.1016/j.pathol.2023.07.011

Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI

2023

Journal Article

Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy

Urquhart, Aaron J., Del Vecchio, Sharon J., Lukas, Darren, Ellis, Robert J., Humphries, Tyrone L.R., Ng, Keng Lim, Samaratunga, Hemamali, Galloway, Graham J., Gobe, Glenda C., Wood, Simon T. and Mountford, Carolyn E. (2023). Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy. Advances in Biomarker Sciences and Technology, 5, 68-75. doi: 10.1016/j.abst.2023.08.001

Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy

2023

Journal Article

Not all tumour necrosis is granular necrosis

Samaratunga, Hemamali, Egevad, Lars and Delahunt, Brett (2023). Not all tumour necrosis is granular necrosis. Pathology, 55 (6), 903-904. doi: 10.1016/j.pathol.2023.03.019

Not all tumour necrosis is granular necrosis

2023

Journal Article

International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2 : grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas

Paner, Gladell P., Kamat, Ashish, Netto, George J., Samaratunga, Hemamali, Varma, Murali, Bubendorf, Lukas, van der Kwast, Theodorus H., Cheng, Liang and the Members of the ISUP Bladder Tumor Consensus Panel (2023). International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2 : grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. American Journal of Surgical Pathology, 48 (1), e11-e23. doi: 10.1097/pas.0000000000002077

International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2 : grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas

2023

Journal Article

Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1

Logan, Jessica M., Hopkins, Ashley M., Martini, Carmela, Sorvina, Alexandra, Tewari, Prerna, Prabhakaran, Sarita, Huzzell, Chelsea, Johnson, Ian R. D., Hickey, Shane M., Ung, Ben S.-Y., Lazniewska, Joanna, Brooks, Robert D., Moore, Courtney R., Caruso, Maria C., Karageorgos, Litsa, Martin, Cara M., O’Toole, Sharon, Bogue Edgerton, Laura, Ward, Mark P., Bates, Mark, Selemidis, Stavros, Esterman, Adrian, Heffernan, Sheena, Keegan, Helen, Ní Mhaolcatha, Sarah, O’Connor, Roisin, Malone, Victoria, Carter, Marguerite, Ryan, Katie ... Brooks, Douglas A. (2023). Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1. Cancers, 15 (12) 3215, 1-12. doi: 10.3390/cancers15123215

Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1

2023

Journal Article

International opinions on grading of urothelial carcinoma: a survey among European Association of Urology and International Society of Urological Pathology members

Beijert, Irene J., Cheng, Liang, Liedberg, Fredrik, Plass, Karin, Williamson, Sean R., Gontero, Paolo, Ribal, Maria J., Babjuk, Marko, Black, Peter C., Kamat, Ashish M., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Masson-Lecomte, Alexandra, Rouprêt, Morgan, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Shariat, Shahrokh F., Mostafid, A. Hugh, Varma, Murali, Shen, Steven, Burger, Maximilian, Tsuzuki, Toyonori, Palou, Joan, Compérat, Eva M., Sylvester, Richard J., van der Kwast, Theo H., van Rhijn, Bas W.G. and Downes, Michelle R. (2023). International opinions on grading of urothelial carcinoma: a survey among European Association of Urology and International Society of Urological Pathology members. European Urology Open Science, 52, 154-165. doi: 10.1016/j.euros.2023.03.019

International opinions on grading of urothelial carcinoma: a survey among European Association of Urology and International Society of Urological Pathology members

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au